Fuse Medical, Inc. (FZMD)
USD 0.09
(-9.91%)
USD 0.09
(-9.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.83 Million USD | 176.05% |
| 2022 | -677.66 Thousand USD | 68.15% |
| 2021 | -1.42 Million USD | -130.35% |
| 2020 | -1.21 Million USD | 72.1% |
| 2019 | -2.3 Million USD | -73.46% |
| 2018 | -1.9 Million USD | -330.73% |
| 2017 | 827.19 Thousand USD | 273.66% |
| 2016 | 3.18 Million USD | 37.89% |
| 2015 | -769.36 Thousand USD | 23.28% |
| 2014 | -1.32 Million USD | -814.78% |
| 2013 | -109.28 Thousand USD | -7.55% |
| 2012 | -101.58 Thousand USD | 17.49% |
| 2011 | -121.92 Thousand USD | 26.37% |
| 2010 | -157.46 Thousand USD | -38.01% |
| 2009 | -110.36 Thousand USD | 12.86% |
| 2008 | -81.78 Thousand USD | 9.44% |
| 2007 | -40.84 Thousand USD | 15.9% |
| 2006 | -88.05 Thousand USD | -17.03% |
| 2005 | -104.11 Thousand USD | 59.49% |
| 2004 | -366.13 Thousand USD | -129.2% |
| 2003 | -168.08 Thousand USD | -2.13% |
| 2002 | -164.57 Thousand USD | 14.81% |
| 2001 | -198.23 Thousand USD | 62.71% |
| 2000 | -369.18 Thousand USD | -1136.0% |
| 1999 | 50 Thousand USD | -61.54% |
| 1998 | 130 Thousand USD | -13.33% |
| 1997 | 150 Thousand USD | -6.25% |
| 1996 | 160 Thousand USD | 14.29% |
| 1995 | 140 Thousand USD | 100.0% |
| 1994 | 70 Thousand USD | 275.0% |
| 1993 | -40 Thousand USD | 93.22% |
| 1992 | -590 Thousand USD | 75.31% |
| 1991 | -2.39 Million USD | -378.0% |
| 1990 | -500 Thousand USD | -900.0% |
| 1989 | -50 Thousand USD | 93.06% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | 401.57 Thousand USD | 403.88% |
| 2023 FY | - USD | 176.05% |
| 2023 Q1 | -132.15 Thousand USD | 77.09% |
| 2022 Q1 | -265.34 Thousand USD | 58.39% |
| 2022 FY | - USD | 68.15% |
| 2022 Q4 | -576.71 Thousand USD | -553.78% |
| 2022 Q3 | 127.09 Thousand USD | 119.05% |
| 2022 Q2 | 58.02 Thousand USD | 121.87% |
| 2021 Q1 | -413.16 Thousand USD | -271.07% |
| 2021 Q2 | -410.54 Thousand USD | 0.64% |
| 2021 Q4 | -637.66 Thousand USD | 4.33% |
| 2021 FY | - USD | -130.35% |
| 2021 Q3 | -666.49 Thousand USD | -62.35% |
| 2020 Q2 | -367.71 Thousand USD | 69.82% |
| 2020 Q4 | 241.51 Thousand USD | 85.69% |
| 2020 FY | - USD | 72.1% |
| 2020 Q1 | -1.21 Million USD | -182.66% |
| 2020 Q3 | 130.06 Thousand USD | 135.37% |
| 2019 FY | - USD | -73.46% |
| 2019 Q1 | -574.38 Thousand USD | -202.99% |
| 2019 Q2 | -128.91 Thousand USD | 77.56% |
| 2019 Q3 | -3.07 Million USD | -2287.1% |
| 2019 Q4 | 1.47 Million USD | 147.9% |
| 2018 FY | - USD | -330.73% |
| 2018 Q2 | -1.95 Million USD | -116.47% |
| 2018 Q3 | 398.91 Thousand USD | 120.35% |
| 2018 Q4 | 557.72 Thousand USD | 39.81% |
| 2018 Q1 | -905.37 Thousand USD | -196.71% |
| 2017 Q4 | 936.18 Thousand USD | 2155.15% |
| 2017 Q2 | 394.00 USD | 100.26% |
| 2017 Q3 | 41.51 Thousand USD | 10436.29% |
| 2017 Q1 | -150.89 Thousand USD | 7.25% |
| 2017 FY | - USD | 273.66% |
| 2016 FY | - USD | 37.89% |
| 2016 Q4 | -162.68 Thousand USD | -43.23% |
| 2016 Q3 | -113.58 Thousand USD | -36.63% |
| 2016 Q1 | -116.91 Thousand USD | -674.13% |
| 2016 Q2 | -83.13 Thousand USD | 28.9% |
| 2015 Q4 | 20.36 Thousand USD | 104.34% |
| 2015 FY | - USD | 23.28% |
| 2015 Q1 | -210.84 Thousand USD | 37.1% |
| 2015 Q2 | -107.25 Thousand USD | 49.13% |
| 2015 Q3 | -469.21 Thousand USD | -337.46% |
| 2014 FY | - USD | -814.78% |
| 2014 Q1 | -113.45 Thousand USD | -135.92% |
| 2014 Q3 | -391.31 Thousand USD | -92.74% |
| 2014 Q4 | -335.19 Thousand USD | 14.34% |
| 2014 Q2 | -203.03 Thousand USD | -78.96% |
| 2013 FY | - USD | -7.55% |
| 2013 Q2 | -22.18 Thousand USD | 8.99% |
| 2013 Q3 | -30.55 Thousand USD | -37.76% |
| 2013 Q4 | -48.08 Thousand USD | -57.37% |
| 2013 Q1 | -24.37 Thousand USD | 24.24% |
| 2012 Q3 | -26.39 Thousand USD | -10.56% |
| 2012 FY | - USD | 17.49% |
| 2012 Q4 | -32.17 Thousand USD | -21.91% |
| 2012 Q2 | -23.87 Thousand USD | -7.45% |
| 2012 Q1 | -22.21 Thousand USD | 23.76% |
| 2011 Q3 | -20.73 Thousand USD | -17.09% |
| 2011 Q4 | -29.13 Thousand USD | -40.51% |
| 2011 Q1 | -24.94 Thousand USD | 58.27% |
| 2011 FY | - USD | 26.37% |
| 2011 Q2 | -17.71 Thousand USD | 28.99% |
| 2010 Q4 | -59.77 Thousand USD | 25.96% |
| 2010 Q2 | -24.32 Thousand USD | 7.03% |
| 2010 Q1 | -26.16 Thousand USD | 27.43% |
| 2010 Q3 | -80.72 Thousand USD | -231.88% |
| 2010 FY | - USD | -38.01% |
| 2009 Q4 | -36.05 Thousand USD | -44.51% |
| 2009 Q3 | -24.94 Thousand USD | 3.52% |
| 2009 Q2 | -25.85 Thousand USD | 16.33% |
| 2009 Q1 | -30.9 Thousand USD | 21.74% |
| 2009 FY | - USD | 12.86% |
| 2008 Q1 | -36.59 Thousand USD | 4.96% |
| 2008 Q3 | -35.65 Thousand USD | -25.85% |
| 2008 FY | - USD | 9.44% |
| 2008 Q4 | -39.48 Thousand USD | -10.75% |
| 2008 Q2 | -28.33 Thousand USD | 22.59% |
| 2007 FY | - USD | 15.9% |
| 2007 Q2 | -30.4 Thousand USD | 9.26% |
| 2007 Q3 | -49.01 Thousand USD | -61.21% |
| 2007 Q1 | -33.5 Thousand USD | 17.61% |
| 2007 Q4 | -38.5 Thousand USD | 21.44% |
| 2006 Q2 | -36.52 Thousand USD | -6.25% |
| 2006 FY | - USD | -17.03% |
| 2006 Q4 | -40.66 Thousand USD | 39.58% |
| 2006 Q1 | -34.37 Thousand USD | 22.59% |
| 2006 Q3 | -67.3 Thousand USD | -84.27% |
| 2005 FY | - USD | 59.49% |
| 2005 Q3 | -30.02 Thousand USD | 9.16% |
| 2005 Q2 | -33.04 Thousand USD | 41.42% |
| 2005 Q1 | -56.41 Thousand USD | -54.26% |
| 2005 Q4 | -44.41 Thousand USD | -47.94% |
| 2004 FY | - USD | -129.2% |
| 2004 Q3 | -266.78 Thousand USD | -694.84% |
| 2004 Q4 | -36.56 Thousand USD | 86.29% |
| 2004 Q2 | -33.56 Thousand USD | 8.58% |
| 2004 Q1 | -36.71 Thousand USD | 23.82% |
| 2003 Q4 | -48.19 Thousand USD | -57.4% |
| 2003 Q1 | -41.83 Thousand USD | 13.82% |
| 2003 Q2 | -47.08 Thousand USD | -12.54% |
| 2003 Q3 | -30.61 Thousand USD | 34.97% |
| 2003 FY | - USD | -2.13% |
| 2002 Q2 | -68.64 Thousand USD | 18.34% |
| 2002 Q1 | -49.56 Thousand USD | -103.7% |
| 2002 Q3 | -23.3 Thousand USD | 142.83% |
| 2002 Q4 | -48.54 Thousand USD | -265.12% |
| 2002 FY | - USD | 14.81% |
| 2001 FY | - USD | 62.71% |
| 2001 Q4 | -53.69 Thousand USD | 7.14% |
| 2001 Q3 | -49.67 Thousand USD | -22.3% |
| 2001 Q2 | -72.4 Thousand USD | 30.81% |
| 2001 Q1 | -96.97 Thousand USD | 12.27% |
| 2000 Q3 | -10 Thousand USD | 90.91% |
| 2000 Q4 | -59.79 Thousand USD | -498.7% |
| 2000 FY | - USD | -1136.0% |
| 2000 Q1 | -130 Thousand USD | -18.18% |
| 2000 Q2 | -110 Thousand USD | 15.38% |
| 1999 Q1 | 30 Thousand USD | -25.0% |
| 1999 Q2 | -10 Thousand USD | -133.33% |
| 1999 FY | - USD | -61.54% |
| 1999 Q3 | -80 Thousand USD | -700.0% |
| 1999 Q4 | -110 Thousand USD | -37.5% |
| 1998 Q3 | 40 Thousand USD | 33.33% |
| 1998 FY | - USD | -13.33% |
| 1998 Q1 | 40 Thousand USD | 0.0% |
| 1998 Q2 | 30 Thousand USD | -25.0% |
| 1998 Q4 | 40 Thousand USD | 0.0% |
| 1997 FY | - USD | -6.25% |
| 1997 Q4 | 40 Thousand USD | 0.0% |
| 1997 Q3 | 40 Thousand USD | 0.0% |
| 1997 Q2 | 40 Thousand USD | -20.0% |
| 1997 Q1 | 50 Thousand USD | 25.0% |
| 1996 Q2 | 30 Thousand USD | -40.0% |
| 1996 FY | - USD | 14.29% |
| 1996 Q1 | 50 Thousand USD | 25.0% |
| 1996 Q4 | 40 Thousand USD | -20.0% |
| 1996 Q3 | 50 Thousand USD | 66.67% |
| 1995 Q1 | 40 Thousand USD | 33.33% |
| 1995 Q2 | 40 Thousand USD | 0.0% |
| 1995 Q4 | 40 Thousand USD | 33.33% |
| 1995 FY | - USD | 100.0% |
| 1995 Q3 | 30 Thousand USD | -25.0% |
| 1994 Q3 | 40 Thousand USD | 0.0% |
| 1994 Q4 | 30 Thousand USD | -25.0% |
| 1994 FY | - USD | 275.0% |
| 1993 Q1 | -10 Thousand USD | 50.0% |
| 1993 Q2 | 60 Thousand USD | 700.0% |
| 1993 FY | - USD | 93.22% |
| 1993 Q3 | -100 Thousand USD | -266.67% |
| 1992 Q1 | -120 Thousand USD | 68.42% |
| 1992 FY | - USD | 75.31% |
| 1992 Q4 | -20 Thousand USD | -111.76% |
| 1992 Q3 | 170 Thousand USD | 168.0% |
| 1992 Q2 | -250 Thousand USD | -108.33% |
| 1991 Q1 | -430 Thousand USD | -4400.0% |
| 1991 FY | - USD | -378.0% |
| 1991 Q4 | -380 Thousand USD | 76.25% |
| 1991 Q3 | -1.6 Million USD | -332.43% |
| 1991 Q2 | -370 Thousand USD | 13.95% |
| 1990 FY | - USD | -900.0% |
| 1990 Q2 | -160 Thousand USD | -6.67% |
| 1990 Q1 | -150 Thousand USD | 21.05% |
| 1990 Q3 | 10 Thousand USD | 106.25% |
| 1990 Q4 | 10 Thousand USD | 0.0% |
| 1989 Q3 | -240 Thousand USD | -50.0% |
| 1989 FY | - USD | 93.06% |
| 1989 Q2 | -160 Thousand USD | 0.0% |
| 1989 Q4 | -190 Thousand USD | 20.83% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 769.115% |
| IR-Med Inc. | -4.89 Million USD | 137.517% |
| Polarean Imaging plc | -11.19 Million USD | 116.394% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -302.429% |
| Avitar, Inc. | -1.66 Million USD | 210.044% |
| AVITA Medical, Inc. | -39.56 Million USD | 104.638% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 257.673% |
| Össur hf. | 137.38 Million USD | 98.664% |
| Zecotek Photonics Inc. | -3.44 Million USD | 153.318% |
| QHSLab, Inc. | -91.29 Thousand USD | 2110.358% |
| Wellstar International, Inc. | -1.35 Million USD | 235.296% |
| Össur hf. | 137.38 Million USD | 98.664% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 81.223% |
| Escalon Medical Corp. | -58.46 Thousand USD | 3239.385% |
| Aurora Spine Corporation | -454.37 Thousand USD | 503.918% |
| BrainsWay Ltd. | -2.31 Million USD | 179.417% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 119.568% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 66.761% |
| Vivos Inc. | -2.79 Million USD | 165.708% |
| MicroPort Scientific Corporation | -347.57 Million USD | 100.528% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 1028.376% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 209.994% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 584.372% |
| Nanomix Corporation | -8.13 Million USD | 122.548% |
| Theraclion SA | -2.05 Million USD | 189.493% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 359.581% |
| Positron Corporation | -1.45 Million USD | 226.386% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 206.588% |
| Lombard Medical, Inc. | -28.06 Million USD | 106.539% |
| ALR Technologies Inc. | -6.4 Million USD | 128.675% |
| Stratec SE | 39.91 Million USD | 95.402% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -1718.171% |
| Heart Tronics, Inc. | -14.85 Million USD | 112.353% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 1651.946% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 113.823% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 120.054% |
| VMS Rehab Systems, Inc. | -68.55 USD | 2677439.168% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 158.711% |
| Ingen Technologies, Inc. | -8639.00 USD | 21344.542% |
| Odyssey Group International, Inc. | -2.13 Million USD | 185.84% |
| United American Healthcare Corporation | -59 Thousand USD | 3210.705% |
| ECGI Holdings, Inc. | -2.99 Million USD | 161.373% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 391.698% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 457.048% |
| Urologix, Inc. | -6.34 Million USD | 128.93% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 248.086% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 339.608% |
| SS Innovations International, Inc. | -20.37 Million USD | 109.007% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 923.684% |
| Smith & Nephew plc | 1 Billion USD | 99.817% |
| NIOX Group Plc | 11.07 Million USD | 83.428% |
| Broncus Holding Corporation | -25.19 Million USD | 107.283% |
| Brain Scientific Inc. | -7.93 Million USD | 123.133% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 119.544% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 10074.543% |